ArticleNeuro-oncology2025

Genome-wide CRISPR-Cas9 screens identify BCL family members as modulators of response to regorafenib in experimental glioma.

Lara Annina Haeusser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.